Filed: 5/15/2025ACC: 0001940272-25-000003
📋 What this filing means
ADAR1 CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 198 equity positions with a total reported market value of $538.67M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
198
Positions
$538.67M
Total AUM (reported)
74.74M
Total Shares
Allocation by class
COM$277.25M51.5%
COM NEW$45.10M8.4%
ALPHA ARCH 1-3$37.59M7.0%
SHS$35.33M6.6%
ADR$34.00M6.3%
SPONSORED ADS$27.31M5.1%
CL A ORD SHS$13.03M2.4%
Portfolio Concentration
Top 3$118.18M21.9%
4–10$119.40M22.2%
11–25$116.38M21.6%
Rest$184.70M34.3%
Top 3 weight
21.9%
Top 10 weight
44.1%
Voting Authority Distribution
Total shares with voting rights: 74.25M
Sole
Full voting authority
74.25M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole198
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings198
Rows:
PROTAGONIST THERAPEUTICS INC
SOLEShares939.67K
TypeSH
Market value$45.44M
8.44%
Sole
939.67K
Shared
0.00
None
0.00
EA SERIES TRUST
SOLEShares337.13K
TypeSH
Market value$37.59M
6.98%
Sole
337.13K
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares3.48M
TypeSH
Market value$35.15M
6.52%
Sole
3.48M
Shared
0.00
None
0.00
ZAI LAB LTD
SOLEShares940.86K
TypeSH
Market value$34.00M
6.31%
Sole
940.86K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares968.87K
TypeSH
Market value$16.56M
3.07%
Sole
968.87K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares390.73K
TypeSH
Market value$15.70M
2.92%
Sole
390.73K
Shared
0.00
None
0.00
KEROS THERAPEUTICS INC
SOLEShares1.49M
TypeSH
Market value$15.15M
2.81%
Sole
1.49M
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares2.21M
TypeSH
Market value$13.81M
2.56%
Sole
2.21M
Shared
0.00
None
0.00
SPDR SER TR
SOLEShares135.59K
TypeSH
Market value$12.44M
2.31%
Sole
135.59K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares339.63K
TypeSH
Market value$11.74M
2.18%
Sole
339.63K
Shared
0.00
None
0.00
JANUX THERAPEUTICS INC
SOLEShares418.67K
TypeSH
Market value$11.30M
2.10%
Sole
153.77K
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares5.12M
TypeSH
Market value$11.22M
2.08%
Sole
5.12M
Shared
0.00
None
0.00
SPRINGWORKS THERAPEUTICS INC
SOLEShares222.78K
TypeSH
Market value$9.83M
1.83%
Sole
207.78K
Shared
0.00
None
0.00
ISHARES TR
SOLEShares103.34K
TypeSH
Market value$8.55M
1.59%
Sole
103.34K
Shared
0.00
None
0.00
TEVA PHARMACEUTICAL INDS LTD
SOLEShares523.77K
TypeSH
Market value$8.05M
1.49%
Sole
523.77K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares122.92K
TypeSH
Market value$7.84M
1.46%
Sole
122.92K
Shared
0.00
None
0.00
PERCEPTIVE CAP SOLUTIONS COR
SOLEShares750K
TypeSH
Market value$7.72M
1.43%
Sole
750K
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares301.13K
TypeSH
Market value$7.37M
1.37%
Sole
301.13K
Shared
0.00
None
0.00
RAPT THERAPEUTICS INC
SOLEShares5.97M
TypeSH
Market value$7.28M
1.35%
Sole
5.97M
Shared
0.00
None
0.00
ARBUTUS BIOPHARMA CORP
SOLEShares1.88M
TypeSH
Market value$6.56M
1.22%
Sole
1.88M
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares48.04K
TypeSH
Market value$6.34M
1.18%
Sole
48.04K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares177.14K
TypeSH
Market value$6.26M
1.16%
Sole
177.14K
Shared
0.00
None
0.00
ANTERIS TECHNOLOGIES GLOBAL
SOLEShares1.68M
TypeSH
Market value$6.11M
1.13%
Sole
1.68M
Shared
0.00
None
0.00
AA MISSION ACQUISITION CORP
SOLEShares578.36K
TypeSH
Market value$6.03M
1.12%
Sole
578.36K
Shared
0.00
None
0.00
SAGE THERAPEUTICS INC
SOLEShares742.50K
TypeSH
Market value$5.90M
1.10%
Sole
742.50K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
PROTAGONIST THERAPEUTICS INCSOLE | COM | 939.67K | SH | $45.44M 8.44% | 939.67K | 0.00 | 0.00 |
EA SERIES TRUSTSOLE | ALPHA ARCH 1-3 | 337.13K | SH | $37.59M 6.98% | 337.13K | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 3.48M | SH | $35.15M 6.52% | 3.48M | 0.00 | 0.00 |
ZAI LAB LTDSOLE | ADR | 940.86K | SH | $34.00M 6.31% | 940.86K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 968.87K | SH | $16.56M 3.07% | 968.87K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 390.73K | SH | $15.70M 2.92% | 390.73K | 0.00 | 0.00 |
KEROS THERAPEUTICS INCSOLE | COM | 1.49M | SH | $15.15M 2.81% | 1.49M | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 2.21M | SH | $13.81M 2.56% | 2.21M | 0.00 | 0.00 |
SPDR SER TRSOLE | BLOOMBERG 1-3 MO | 135.59K | SH | $12.44M 2.31% | 135.59K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 339.63K | SH | $11.74M 2.18% | 339.63K | 0.00 | 0.00 |
JANUX THERAPEUTICS INCSOLE | COM | 418.67K | SH | $11.30M 2.10% | 153.77K | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 5.12M | SH | $11.22M 2.08% | 5.12M | 0.00 | 0.00 |
SPRINGWORKS THERAPEUTICS INCSOLE | COM | 222.78K | SH | $9.83M 1.83% | 207.78K | 0.00 | 0.00 |
ISHARES TRSOLE | 1 3 YR TREAS BD | 103.34K | SH | $8.55M 1.59% | 103.34K | 0.00 | 0.00 |
TEVA PHARMACEUTICAL INDS LTDSOLE | SPONSORED ADS | 523.77K | SH | $8.05M 1.49% | 523.77K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 122.92K | SH | $7.84M 1.46% | 122.92K | 0.00 | 0.00 |
PERCEPTIVE CAP SOLUTIONS CORSOLE | CL A ORD SHS | 750K | SH | $7.72M 1.43% | 750K | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 301.13K | SH | $7.37M 1.37% | 301.13K | 0.00 | 0.00 |
RAPT THERAPEUTICS INCSOLE | COM | 5.97M | SH | $7.28M 1.35% | 5.97M | 0.00 | 0.00 |
ARBUTUS BIOPHARMA CORPSOLE | COM | 1.88M | SH | $6.56M 1.22% | 1.88M | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 48.04K | SH | $6.34M 1.18% | 48.04K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 177.14K | SH | $6.26M 1.16% | 177.14K | 0.00 | 0.00 |
ANTERIS TECHNOLOGIES GLOBALSOLE | COM | 1.68M | SH | $6.11M 1.13% | 1.68M | 0.00 | 0.00 |
AA MISSION ACQUISITION CORPSOLE | ORD SHS CL A | 578.36K | SH | $6.03M 1.12% | 578.36K | 0.00 | 0.00 |
SAGE THERAPEUTICS INCSOLE | COM | 742.50K | SH | $5.90M 1.10% | 742.50K | 0.00 | 0.00 |
Page 1 of 8
…